Cargando…
PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428843/ http://dx.doi.org/10.1097/01.HS9.0000977380.42549.8a |
_version_ | 1785090567283146752 |
---|---|
author | Vázquez, Celia Martinez Charavia, Marta Callejas Miranda, Daniel Gainza Cilleruelo, Jose Maria Aspa Guzman, López de Hontanar Antonio, Rodríguez Barquero Pedro Herreros, Paula Gili Galina, Motornaya Gómez, Maria Menor Pérez, Carlota Portocarrero de Las Heras Ramírez, Patricia García Julio, Garcia Suarez |
author_facet | Vázquez, Celia Martinez Charavia, Marta Callejas Miranda, Daniel Gainza Cilleruelo, Jose Maria Aspa Guzman, López de Hontanar Antonio, Rodríguez Barquero Pedro Herreros, Paula Gili Galina, Motornaya Gómez, Maria Menor Pérez, Carlota Portocarrero de Las Heras Ramírez, Patricia García Julio, Garcia Suarez |
author_sort | Vázquez, Celia Martinez |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104288432023-08-17 PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS Vázquez, Celia Martinez Charavia, Marta Callejas Miranda, Daniel Gainza Cilleruelo, Jose Maria Aspa Guzman, López de Hontanar Antonio, Rodríguez Barquero Pedro Herreros, Paula Gili Galina, Motornaya Gómez, Maria Menor Pérez, Carlota Portocarrero de Las Heras Ramírez, Patricia García Julio, Garcia Suarez Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428843/ http://dx.doi.org/10.1097/01.HS9.0000977380.42549.8a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Vázquez, Celia Martinez Charavia, Marta Callejas Miranda, Daniel Gainza Cilleruelo, Jose Maria Aspa Guzman, López de Hontanar Antonio, Rodríguez Barquero Pedro Herreros, Paula Gili Galina, Motornaya Gómez, Maria Menor Pérez, Carlota Portocarrero de Las Heras Ramírez, Patricia García Julio, Garcia Suarez PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title | PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title_full | PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title_fullStr | PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title_full_unstemmed | PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title_short | PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS |
title_sort | pb2676: are novel therapeutic opportunities leading us to overtreat patients?: a review of end-of-life situation in haematological patients |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428843/ http://dx.doi.org/10.1097/01.HS9.0000977380.42549.8a |
work_keys_str_mv | AT vazquezceliamartinez pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT charaviamartacallejas pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT mirandadanielgainza pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT cilleruelojosemariaaspa pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT guzmanlopezdehontanar pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT antoniorodriguezbarqueropedro pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT herrerospaulagili pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT galinamotornaya pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT gomezmariamenor pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT perezcarlotaportocarrerodelasheras pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT ramirezpatriciagarcia pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients AT juliogarciasuarez pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients |